Pharma marketing in the UAE is not blocked. It is gated. The Ministry of Health and Prevention approves health advertising content before it runs, the Dubai Health Authority layers its own requirements inside Dubai, and the brands that move fastest are the ones whose briefs were written inside the rules from day one rather than edited into compliance at the end.
The two gates
MOHAP is the federal gate: health advertisements require approval before publication, and that covers claims, imagery, and the channels the campaign will run on. DHA governs health facilities and professionals advertising within Dubai. Practical consequence: a regional campaign needs its approval pathway mapped before creative development starts, because the approval timeline is part of the media plan, not an afterthought.
What is allowed
Disease awareness campaigns that educate without naming a prescription product. Branded communication for over-the-counter products with approved claims. Screening and prevention drives run with healthcare partners. Patient education content reviewed by medical affairs. Campaigns built around World Health Days, which give pharma brands a legitimate public-health platform. There is far more creative room inside these lanes than most briefs ever use.
What gets blocked
Prescription product promotion to the general public. Efficacy claims without approved substantiation. Before-and-after imagery that implies guaranteed outcomes. Testimonials presented as clinical evidence. Discounting and prize promotions around medicines. Fear-based creative that exaggerates risk to drive action. Most rejections we see are not bad intent. They are briefs written for another market and submitted unchanged.
How to brief inside the rules
Write the regulatory position into the brief itself: what category of communication this is, which claims are approved, which body must clear it, and how long clearance takes. Put medical affairs in the first creative review, not the last. Build the big idea on emotion and education rather than product claims, then let the claim architecture sit underneath. The Roche campaigns we have run since 2019 follow exactly this pattern: the creative leads with humanity, the compliance is engineered in from the first line of the brief.
Key takeaways
- UAE pharma marketing is gated, not blocked. MOHAP approves content before it runs, DHA adds Dubai-level requirements.
- Disease awareness, OTC with approved claims, and health-day platforms are wide-open lanes.
- Prescription promotion to the public, unsubstantiated claims, and outcome imagery get rejected.
- Write the regulatory position into the brief and put medical affairs in the first review.
- Approval timelines are part of the media plan, not an afterthought.
Sources
- UAE Ministry of Health and Prevention health advertising requirements.
- Dubai Health Authority advertising guidelines.
- Add Hype healthcare campaign work for Roche, Accu-Chek, Bioderma, and MSL since 2019.
Add Hype has briefed, cleared, and shipped healthcare campaigns across the UAE since 2019. If your next campaign needs to move fast inside the rules, write to us at hype@weaddhype.com.
.jpeg)
.png)
